Another study challenged ovarian cancer cell lines with six different chemotherapies and found increased ABCG2 mRNA expression in vincristine- (P < 0.01) and topotecan-resistant (P < 0.001) cell lines[63]. This evidence concerns the gene ABCG2 and ovarian carcinoma.